The Leona M. and Harry B. Helmsley Charitable Trust

Thetis Pharmaceuticals LLC is a biopharmaceutical company based in Branford, Connecticut, founded in 2011. The company specializes in developing immuno-resolving therapeutic solutions aimed at treating inflammatory bowel diseases and other inflammatory conditions. Utilizing its HEALER technology platform, Thetis Pharmaceuticals focuses on the pharmacology of lipids to create new and patented small molecule drugs that promote tissue regeneration and mitigate inflammation. Their research has advanced the development of resolvins, which act as potent agonists of inflammation resolution and tissue repair. These therapies are designed to counteract excessive inflammatory responses while preserving immune function, thereby enabling healthcare professionals to better manage patients' inflammatory conditions.

TIXiMED is a biotechnology company focused on developing and commercializing oral therapeutics for the treatment of Type 1 and Type 2 diabetes. The company aims to improve the quality of life for diabetic patients by providing alternatives that protect against diabetes and non-alcoholic fatty liver disease (NAFLD). Its therapies work by lowering glucagon levels and inhibiting glucose production in the liver, which can help reduce the need for multiple daily insulin injections and continuous insulin infusions. Through its innovations, TIXiMED seeks to enhance patient outcomes while lowering overall treatment costs.

The Mount Sinai School of Medicine in New York, New York, one of the only schools in the nation with a distinctive Department of Medical Education that continually improves the quality of its teaching, offers students a variety of medical academics to shape them into compassionate assistants, professionals and industry leaders. The academics available at Mount Sinai include master's and PhD programs in areas like: * Science and Medicine * Patient Oriented Research Training and Leadership * Biomedical Sciences * Genetic Counseling * Clinical Research Besides its degree-granting programs, Mount Sinai also offers an extensive number of residencies and fellowships, some of which include: * Anesthesiology * Cardiology * Dental Medicine * Emergency Medicine * Hematology and Oncology College life at Mount Sinai is fully-immersed in the medical sciences. All your instruction, provided by medical professionals, will be delivered in a hospital setting, allowing you to familiarize yourself with the many resources and technology used in today's hospitals. Mount Sinai is also home to the Levy Library, which is fully-stocked with myriad medical resources, from journals to professional magazines to textbooks. Since each program has different admissions requirements, please contact Mount Sinai for more information on a program that interests you and your career goals. Tuition assistance is available to students through fellowship programs and Mount Sinai grants and scholarships. For more information federal sources of financial aid, please contact an aid advisor from the school.

NYC Health + Hospitals provides health care services. They provide dental care, depression care, diabetes care, abortion care, and smoking cessation services. The corporation operates a network of hospitals, community-based health clinics, long-term care, and rehabilitation facilities, home care services, correctional health services, and MetroPlus, a health plan.

Brigham and Women's Hospital (BWH) is a prominent medical institution located in Boston, Massachusetts, and serves as the largest hospital within the Longwood Medical and Academic Area. It is the second largest teaching affiliate of Harvard Medical School, featuring 793 beds. BWH, in partnership with Massachusetts General Hospital, is a founding member of Partners HealthCare, the largest healthcare provider in the state. The hospital is renowned for its comprehensive patient care, biomedical research, and educational programs, especially in fields such as heart and vascular care, cancer treatment, neurology, orthopedics, and women's health. BWH is also the second largest recipient of National Institutes of Health funding in the country, contributing to significant medical advancements, including organ transplantation. The hospital offers a wide array of outpatient services and operates a network of clinics and primary care health centers, ensuring accessible healthcare not only locally but also through global initiatives in 120 countries. Additionally, BWH is dedicated to promoting health equity and addressing healthcare disparities.

Thetis Pharmaceuticals LLC is a biopharmaceutical company based in Branford, Connecticut, founded in 2011. The company specializes in developing immuno-resolving therapeutic solutions aimed at treating inflammatory bowel diseases and other inflammatory conditions. Utilizing its HEALER technology platform, Thetis Pharmaceuticals focuses on the pharmacology of lipids to create new and patented small molecule drugs that promote tissue regeneration and mitigate inflammation. Their research has advanced the development of resolvins, which act as potent agonists of inflammation resolution and tissue repair. These therapies are designed to counteract excessive inflammatory responses while preserving immune function, thereby enabling healthcare professionals to better manage patients' inflammatory conditions.

Shamir Medical Centre is an advanced clinic for twin mothers whose pregnancies will receive tests outside of the health basket at no cost, such as a non-invasive blood test for chromosomal abnormalities, a preeclampsia test, a screening test to find and prevent premature birth, along with a variety of other recognized tests during pregnancy, like the nuchal test. The clinic offers one-on-one or group parent education. The sessions will be held without the kids present.

Beyond Type 1 is a nonprofit organization changing what it means to live with diabetes. Through platforms, programs, resources, and grants, Beyond Type 1 is uniting the global diabetes community and providing solutions to improve lives today. Founded in 2015 with a focus on education, advocacy and the path to a cure for Type 1 diabetes, Beyond Type 1 has grown to also include programs for those with Type 2 diabetes.

The University of Massachusetts Medical School (UMMS), founded in 1962 and located in Worcester, Massachusetts, is dedicated to providing affordable, high-quality medical education with a focus on increasing the number of primary care physicians in underserved areas. Recognized by U.S. News & World Report as a leading institution for primary care education, UMMS aims to enhance health and wellness in diverse communities both locally and globally. The university is committed to innovation in education, research, healthcare delivery, and public service, while its assets are managed by an executive team to support its mission effectively.

Capillary Biomedical, Inc. is a medical device company founded in 2014 and located in Irvine, California. The company focuses on developing innovative technologies for diabetes management, particularly in simplifying glucose monitoring and insulin delivery. As a spin-out from the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University, Capillary Biomedical is dedicated to reducing the burden of diabetes on patients and the healthcare system. Its flagship product features a kink-proof, flexible, multiport cannula designed for reliable and comfortable insulin delivery, with an emphasis on a straightforward one-handed insertion process. This user-friendly design aims to assist diabetes patients in achieving better blood glucose control.

DreaMed Diabetes, Ltd. is a medical device and software-as-a-service company focused on diabetes treatment and management. Founded in 2014 and based in Israel, the company is known for its innovative solutions, including Glucositter, a closed-loop insulin delivery system that monitors glucose levels in real-time and adjusts insulin delivery accordingly. DreaMed Diabetes has made significant advancements in decision support tools for diabetes management and was the first company to receive FDA clearance for a decision support system that utilizes data from continuous glucose monitors and insulin pumps. Its Advisor Pro software, developed by diabetes professionals, leverages artificial intelligence to enable healthcare providers to quickly analyze patient data and determine optimal treatment plans. This system aims to improve patient outcomes by facilitating frequent titration changes and enhancing online monitoring, ultimately helping to lower A1C levels and reduce the risk of complications. DreaMed Diabetes emphasizes patient-centered care, ensuring that all individuals receive high-quality treatment regardless of their circumstances.

Tidepool is a company based in the United States that focuses on making diabetes data more accessible and meaningful for individuals with diabetes, their care teams, and researchers. Utilizing advanced scientific techniques and patented technology, Tidepool offers an analytics platform that allows users to track and assess their diabetes-related information. The platform aims to provide insights into how personal characteristics, such as personality and mood, influence daily performance. This is achieved through interactive and engaging games that users can access daily. Additionally, Tidepool plans to integrate with various health-tracking devices, enhancing the user's ability to manage their diabetes effectively.

Biorasis, established in December 2007, focuses on developing needle-implantable biosensors for real-time, continuous monitoring of various bio-analytes. Initially aimed at commercializing a miniaturized sensor platform from UCONN and OSCI for glucose monitoring, the company is expanding its technology to track other critical metabolites associated with disorders such as cardiovascular issues, cancer, liver and kidney abnormalities, stroke, and epilepsy. Biorasis's biosensors enable effective diabetes management and enhance metabolic monitoring for drug research and development, allowing healthcare professionals to minimize tissue damage during implantation procedures.

Beginning in 1993, Avera offered eCARE Specialty Clinic services to rural, frontier and critical access hospitals that were part of the Avera Health system. Ten years later, Avera eCARE expanded to provide eCARE ICU, the first 24-hour, on-demand service that allows staff at partner facilities to connect virtually via a video and audio call for immediate assistance from board-certified providers. In addition, Avera eCARE delivered 24/7 access to a wide range of medical specialists and referrals to specialty care for a growing number of underserved populations and communities. Then, in 2009, through a grant from The Leona M. and Harry B. Helmsley Charitable Trust, Avera eCARE launched eCARE Emergency and eCARE Pharmacy for all of Avera’s rural hospitals. Additional funding from the Helmsley Charitable Trust and other sources allowed expansion to over 200 Avera facilities across eight states and the ability to serve partners outside Avera Health. By 2012, Avera eCARE services were available for long-term care and correctional facilities. At Avera eCARE, their telemedicine professionals work together 24/7 in the eHELM, their virtual hospital hub, also created in 2012 with the assistance of the Helmsley Charitable Trust. By staffing their central facility around the clock, their partners and patients benefit from the multidisciplinary collaboration of medical specialists within their telemedicine teams 24/7/365.

Zucara Therapeutics Inc. is a biotechnology company based in Toronto, Canada, with an additional office in Vancouver. Founded in 2014, the company focuses on developing innovative therapeutics aimed at preventing hypoglycemia, or low blood sugar, in patients with diabetes. Its lead pre-clinical technology targets somatostatin type 2 receptors in the pancreas, which are inadequately regulated in individuals with Type 1 diabetes. By blocking these receptors, Zucara's treatment aims to prevent hypoglycemia and restore natural glucose levels in the bloodstream. This approach represents a significant advancement over existing therapies, which typically only address hypoglycemia after it has occurred, rather than preventing it from happening in the first place.

Cody Regional Health is focusing on putting the patient first. Located in Cody, Wyo., their hospital serves as a primary, full-service medical center to communities throughout the Big Horn Basin. They also have an adjacent Long Term Care Center licensed for 94 beds and a 20-bed chemical dependency center. The Hospital has adopted the Planetree philosophy as a model of health care. The Planetree model strives to enhance patient comfort by personalizing, humanizing and demystifying the health care experience.

Beyond Type 1 is a nonprofit organization changing what it means to live with diabetes. Through platforms, programs, resources, and grants, Beyond Type 1 is uniting the global diabetes community and providing solutions to improve lives today. Founded in 2015 with a focus on education, advocacy and the path to a cure for Type 1 diabetes, Beyond Type 1 has grown to also include programs for those with Type 2 diabetes.

Salk Institute for Biological Studies conducts research on molecular biology and genetics, neurosciences, and plant biology. The research is conducted under the guidance of 59 faculty investigators and more than 850 scientific staff, including visiting scientists, postdoctoral fellows, and graduate students. The institute’s operates to identify therapies and treatments for a range of diseases such as cancer, AIDS, Alzheimer's disease, cardiovascular disorders, anomalies of the brain, and birth defects. Six key areas represent strategic research priorities: chemistry and proteomics, stem cell biology, cell biology, regulatory biology, metabolic research, and computational and theoretical biology. The Institute has trained more than 2,700 scientists, out of which five have won Nobel prizes. Salk is home to nine Howard Hughes Medical Investigators and 14 members of the National Academy of Sciences. NCI Cancer Center, Crick-Jacobs Center, Glenn Center for Aging Research, Helmsley Center for Genomic Medicine, Waitt Advanced Biophotonics Center, and Glenn Center for Aging Research are some of the research centers operated by Salk Institute for Biological Studies. The Salk Institute for Biological Studies was established in the 1960s by Jonas Salk and is based in California, United States.